Mayne Pharma Group Limited

ASX:MYX 주식 보고서

시가총액: AU$359.5m

Mayne Pharma Group 관리

관리 기준 확인 1/4

Mayne Pharma Group CEO는 Shawn O’Brien, Oct2022 에 임명되었습니다 의 임기는 2.08 년입니다. 총 연간 보상은 A$ 2.06M, 46.5% 로 구성됩니다. 46.5% 급여 및 53.5% 보너스(회사 주식 및 옵션 포함). 는 A$ 269.61K 가치에 해당하는 회사 주식의 0.075% 직접 소유합니다. 269.61K. 경영진과 이사회의 평균 재임 기간은 각각 2.8 년과 2.7 년입니다.

주요 정보

Shawn O’Brien

최고 경영자

AU$2.1m

총 보상

CEO 급여 비율46.5%
CEO 임기2.1yrs
CEO 소유권0.07%
경영진 평균 재임 기간2.8yrs
이사회 평균 재임 기간2.7yrs

최근 관리 업데이트

Recent updates

A Piece Of The Puzzle Missing From Mayne Pharma Group Limited's (ASX:MYX) 30% Share Price Climb

Sep 01
A Piece Of The Puzzle Missing From Mayne Pharma Group Limited's (ASX:MYX) 30% Share Price Climb

Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade

Mar 06
Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade

Analysts Just Slashed Their Mayne Pharma Group Limited (ASX:MYX) EPS Numbers

Dec 03
Analysts Just Slashed Their Mayne Pharma Group Limited (ASX:MYX) EPS Numbers

Is Mayne Pharma Group (ASX:MYX) Using Too Much Debt?

Dec 01
Is Mayne Pharma Group (ASX:MYX) Using Too Much Debt?

Is Mayne Pharma Group (ASX:MYX) A Risky Investment?

Apr 12
Is Mayne Pharma Group (ASX:MYX) A Risky Investment?

Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade

Mar 01
Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade

We Think Mayne Pharma Group Limited's (ASX:MYX) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 16
We Think Mayne Pharma Group Limited's (ASX:MYX) CEO Compensation Package Needs To Be Put Under A Microscope

Mayne Pharma Group (ASX:MYX) Is Making Moderate Use Of Debt

Nov 10
Mayne Pharma Group (ASX:MYX) Is Making Moderate Use Of Debt

Mayne Pharma Group (ASX:MYX) Is Carrying A Fair Bit Of Debt

May 17
Mayne Pharma Group (ASX:MYX) Is Carrying A Fair Bit Of Debt

Is Mayne Pharma Group Limited (ASX:MYX) Trading At A 37% Discount?

Mar 22
Is Mayne Pharma Group Limited (ASX:MYX) Trading At A 37% Discount?

How Many Mayne Pharma Group Limited (ASX:MYX) Shares Did Insiders Buy, In The Last Year?

Mar 01
How Many Mayne Pharma Group Limited (ASX:MYX) Shares Did Insiders Buy, In The Last Year?

What You Need To Know About Mayne Pharma Group Limited's (ASX:MYX) Investor Composition

Feb 08
What You Need To Know About Mayne Pharma Group Limited's (ASX:MYX) Investor Composition

Mayne Pharma Group Limited's (ASX:MYX) Shift From Loss To Profit

Jan 18
Mayne Pharma Group Limited's (ASX:MYX) Shift From Loss To Profit

Mayne Pharma Group's (ASX:MYX) Shareholders Are Down 75% On Their Shares

Dec 27
Mayne Pharma Group's (ASX:MYX) Shareholders Are Down 75% On Their Shares

Would Mayne Pharma Group (ASX:MYX) Be Better Off With Less Debt?

Dec 09
Would Mayne Pharma Group (ASX:MYX) Be Better Off With Less Debt?

A Quick Analysis On Mayne Pharma Group's (ASX:MYX) CEO Compensation

Nov 24
A Quick Analysis On Mayne Pharma Group's (ASX:MYX) CEO Compensation

CEO 보상 분석

Shawn O’Brien 의 보수는 Mayne Pharma Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024AU$2mAU$959k

-AU$169m

Mar 31 2024n/an/a

-AU$221m

Dec 31 2023n/an/a

-AU$274m

Sep 30 2023n/an/a

-AU$296m

Jun 30 2023AU$2mAU$663k

-AU$317m

보상 대 시장: Shawn 의 총 보상 ($USD 1.37M )은 Australian 시장( $USD 665.93K ).

보상과 수익: 회사가 수익성이 없는 동안 Shawn 의 보상이 증가했습니다.


CEO

Shawn O’Brien (65 yo)

2.1yrs

테뉴어

AU$2,062,194

보상

Mr. Shawn Patrick O'Brien, B.Sc has been CEO, MD & Director at Mayne Pharma Group Limited since October 1, 2022. He serves as the Chief Commercial Advisor at Melanovus Oncology, Inc. Mr. O'Brien is a found...


리더십 팀

이름위치테뉴어보상소유권
Shawn O’Brien
CEO, MD & Director2.1yrsAU$2.06m0.075%
A$ 269.6k
Aaron Gray
Chief Financial Officer2.3yrsAU$1.31m0.064%
A$ 229.0k
Kimberly Parker
Executive VP & General Counsel2.8yrs데이터 없음데이터 없음
Brant Schofield
Executive Vice President of Corporate Development3.8yrsAU$1.29m데이터 없음
Erinn Nathaniel
Director of Global Human Resources1.8yrs데이터 없음데이터 없음
Daniel Moore
Executive Vice President of Commercial5.2yrs데이터 없음데이터 없음
Frank Casty
Executive VP & Global Chief Medical Officer1.8yrs데이터 없음데이터 없음
Brenton Walter
Financial Controller20.3yrs데이터 없음데이터 없음
Laura Loftus
Associate General Counsel & Company Secretary4.7yrs데이터 없음데이터 없음

2.8yrs

평균 재임 기간

경험이 풍부한 관리: MYX 의 관리팀은 경험 ( 2.8 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Shawn O’Brien
CEO, MD & Director2.1yrsAU$2.06m0.075%
A$ 269.6k
Frank Condella
Independent Non-Executive Chairman6.5yrsAU$305.40k0.081%
A$ 292.1k
Bruce Robinson
Independent Non-Executive Director10.3yrsAU$219.39k0.039%
A$ 140.6k
Patrick Blake
Independent Non-Executive Director6.4yrsAU$218.36k0.027%
A$ 97.9k
Ann Custin
Independent Non-Executive Director2.7yrsAU$235.16k0.026%
A$ 94.6k
Kathryn MacFarlane
Independent Non-Executive Director2.8yrsAU$215.84k0.047%
A$ 168.3k
Anne Lockwood
Independent Non Executive Directorless than a yearAU$117.49k데이터 없음
David Petrie
Non-Executive Director2.2yrsAU$217.86k데이터 없음

2.7yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: MYX 의 이사회경험(평균 재직 기간 2.7 년)으로 간주되지 않으므로 새 이사회가 필요합니다.